Azacitidine is an anti-metabolite used to treat myelodysplastic syndromes and acute myeloid leukemia. It works by inhibiting DNA synthesis, promoting normal blood cell production. Azacitidine is effective in managing blood cancers. In summary, it plays a vital role in hematological therapy.
Azacitidine incorporates into RNA and DNA, disrupting nucleic acid synthesis and promoting differentiation of abnormal cells.